Use of 2-phenyl-1, 2-ethanediol- (di) carbamates for treating epileptogenesis and epilepsy

Details for Australian Patent Application No. 2005287174 (hide)

International Classifications

Event Publications

5 April 2007 PCT application entered the National Phase

PCT publication WO2006/033947 Priority application(s): WO2006/033947

24 May 2007 Change of Name(s) of Applicant(s), Section 104

Janssen Pharmaceutica, N.V. The name of the applicant has been changed to Janssen Pharmaceutica, N.V.; SK Corporation

12 January 2012 Application Accepted

Published as AU-B-2005287174

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.